Stock NB3 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Neurocrine Biosciences, Inc. Deutsche Boerse AG

Equities

NB3

US64125C1099

Market Closed - Deutsche Boerse AG
Other stock markets
 11:32:51 07/06/2024 am IST 		5-day change 1st Jan Change
121.6 EUR -0.37% Intraday chart for Neurocrine Biosciences, Inc. -1.93% +2.36%
05/06 Transcript : Neurocrine Biosciences, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 02:30 PM
03/06 Neurocrine Biosciences, Inc. Announces Publication of Primary CAHtalyst Adult Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROCRINE BIOSCIENCES, INC.
Bio Therapeutic Drugs
-0.37%-1.93%+2.36%+38.77%+70.90% 13.58B - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. NB3 Stock
  5. Charts Neurocrine Biosciences, Inc.
  6. Comparison Chart